8-K
filed January 2, 2026, 6:59 PM ET
ticker AMS
CIK 0000744825
other material
confidence high
sentiment negative
materiality 0.65
American Shared Hospital Services will restate Q3 2025 10-Q due to debt classification error
AMERICAN SHARED HOSPITAL SERVICES
- Audit committee concluded unaudited Sept 30, 2025 balance sheet misclassified $8.6M in debt as long-term; should be current liabilities.
- Error arose after Fifth Third default notice for failing to maintain $5M unrestricted cash minimum; cross-default under DFC loan.
- Restatement will reclassify $7.95M (Fifth Third) and $0.65M (DFC) debt; no effect on revenue, net loss, or cash flows.
- Company is seeking waiver/amendment from Fifth Third; no acceleration of obligations yet.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-26-000099
- form_type
- 8-K
- ticker
- AMS
- cik
- 0000744825
- company_name
- AMERICAN SHARED HOSPITAL SERVICES
- filed_at
- 2026-01-02T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:37.633105+00:00
- generated_at
- 2026-05-16T11:52:05.617071+00:00
- sec_items
- ["4.02", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-26-000099
- json_url
- https://secwatch.observer/filing/0001437749-26-000099.json
- markdown_url
- https://secwatch.observer/filing/0001437749-26-000099.md
- text_url
- https://secwatch.observer/filing/0001437749-26-000099.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/744825/000143774926000099/0001437749-26-000099-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/744825/000143774926000099/asha20251230_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GWLL
Goldenwell Biotech to restate three quarterly reports over $9,840 legal fee timing errors
GOLDENWELL BIOTECH, INC.
May 26, 2026, 8:17 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
the Company’s independent registered public accounting firm, Michael Gillsepie & Associates, PLLC (“Gillespie & Associates”), notified the Company that the Company did not follow US GAAP because an invoice dated September 23, 2025, from the Company’s legal counsel in the amount of $9,840 to the Company, which covered legal services rendered to the Company between May 21, 2024 and September 23, 2025, should have been recorded in the fiscal quarters when services were performed
Filing page
SEC filing
NMTC
NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance
NEUROONE MEDICAL TECHNOLOGIES Corp
May 22, 2026, 4:30 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”), after discussion with management, determined that the Company’s previously issued interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 12, 2026 (the “Previous Filing”), should no longer be relied upon and should be restated because of accounting errors relating to revenue recognition.
Filing page
SEC filing
CGC
Canopy Growth restates FY2024-2025 financials due to warrant classification error; Q4/FY2026 results delayed to June 15
Canopy Growth Corp
May 15, 2026, 5:06 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
the audit committee of the board of directors of the Company (the “Audit Committee”) was made aware of and, after discussion with senior management of the Company, concluded that the Company’s previously issued (i) audited consolidated financial statements for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2024 10-K”), (ii) audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2025 10-K”) and (iii) unaudited consolidated financial statements for the quarterly periods ended September 30, 2023, December 31, 2023, June 30, 2024, September 30, 2024, December 31, 2024, June 30, 2025, September 30, 2025, and December 31, 2025, included in the Company’s Quarterly Reports on Form 10-Q for such quarterly periods (collectively, the “Prior Financial Statements”), should no longer be relied upon
Filing page
SEC filing
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
PreAxia restates Aug 31, 2025 financials; stock award errors, material weakness
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
April 21, 2026, 7:59 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
On April 9, 2026, the management of PreAxia Health care Payment Systems Inc., a Nevada corporation (the “Company”), identified material errors in the previously released financial statements for the three months ended August 31, 2025 (the “Non-Reliance Period”) and concluded that such financial statements should no longer be relied upon.
Filing page
SEC filing
CNTY
Century Casinos dismisses Grant Thornton, appoints EY as new auditor; cites material weaknesses
CENTURY CASINOS INC /CO/
May 28, 2026, 4:11 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
(b) Engagement of Independent Registered Public Accounting Firm On May 22, 2026, the Audit Committee appointed Ernst & Young LLP (“EY”) as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2026.
Filing page
SEC filing
SVCO
Silvaco dismisses Baker Tilly, appoints KPMG as independent auditor
Silvaco Group, Inc.
May 27, 2026, 5:25 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
on May 27, 2026, KPMG LLP (“KPMG”) was engaged as the Company’s independent registered public accounting firm
Filing page
SEC filing
ALUR
Allurion Technologies dismisses Deloitte & Touche, appoints CBIZ; discloses material weaknesses
ALLURION TECHNOLOGIES, INC.
May 27, 2026, 4:35 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
On May 22, 2026 (the “Effective Date”), Deloitte was dismissed as our independent registered public accounting firm.
Filing page
SEC filing
WAST
Waste Energy Corp. replaces independent auditor; Integrität resigns, M&K CPAs appointed
WASTE ENERGY CORP.
May 22, 2026, 4:24 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On December 27, 2025, the Audit Committee of the Board of Directors of American Shared Hospital Services (the “ Company ”) concluded, after discussions with management and Baker Tilly US, LLP, the Company’s independent registered public accounting firm, that the Company’s unaudited condensed balance sheet that was part of the Company’s financial statements as of September 30, 2025 (the “ Previous Financial Statements ”), included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission (the “ SEC ”) on November 14, 2025 (the “ Q3 2025 Quarterly Report ”), should no longer be relied upon as it relates to the classification of the Company’s indebtedness as of September 30, 2025.
Comparable filing
On May 21, 2026, the Audit Committee and Board of Directors approved the engagement of M&K CPAs, PLLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, subject to completion of customary client acceptance procedures and execution of a final engagement letter.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.